Innovative Technology by MolecuLight Inc. Poised to Revolutionize Chronic Wound Care (September 2015)

Ontario healthcare innovator, MolecuLight Inc., is developing a hand-held optical imaging technology designed to visualize bacteria in real-time at the point-of-care. Founded by Dr. Ralph DaCosta, Scientist at The Princess Margaret Cancer Centre and Techna Institutute in partnership with University Health Network, MolecuLight’s device is revolutionizing wound care and strengthening Ontario’s role as a global innovation leader in health care.

Founded in June 2012 by University Health Network Scientist, Dr. Ralph DaCosta, MolecuLight Inc. has joined the ranks of research hospital spin-off companies strengthening Ontario’s role as a global innovation hub. Located in Toronto’s MaRS Centre, MolecuLight employs a multidisciplinary team of top researchers, engineers, clinical experts and international business leaders to commercialize its first medical device product for global markets: MolecuLight i:XTM.

Click to read more.